Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend Regimen

Publisher： Karger

E-ISSN： 1423-0267|238|3|172-178

ISSN： 0030-3755

Source： Ophthalmologica, Vol.238, Iss.3, 2017-08, pp. : 172-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes when Switching from a pro re nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-12 ,pp. : 201-206

Karger

Access to resources Recommend Favorite

One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 237, Iss. 3, 2017-03 ,pp. : 139-144

Karger

Access to resources Recommend Favorite

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Spectral-Domain versus Time Domain Optical Coherence Tomography before and after Ranibizumab for Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 46, Iss. 3, 2011-03 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

One-Year Outcomes of the Treat-and-Extend Approach with Aflibercept in Age-Related Macular Degeneration: Effects on Typical Choroidal Neovascularization and Retinal Angiomatous Proliferation

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-12 ,pp. : 215-222

Karger

Access to resources Recommend Favorite